ArticleCureus2026
Reducing Daytime Sedation While Preserving Motor Function in Parkinson's Disease Psychosis: A Case Report of Psychotropic Timing and Deprescribing.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Psychosis and behavioral dysregulation in advanced Parkinson's disease (PD) are commonly managed with psychotropic medications that may worsen motor symptoms or contribute to excessive daytime sedation. We describe a 77-year-old male with advanced PD and psychosis admitted following agitation-related self-removal of a percutaneous endoscopic gastrostomy (PEG) tube. Collateral history revealed persistent morning somnolence that limited participation in physical therapy and daily care activities. His medication regimen included multiple agents with sedating properties, raising concern for cumulative pharmacologic burden contributing to impaired daytime function. A structured approach to medication adjustments was implemented, focusing on selective deprescribing, consolidating sedating medications to evening dosing, and simplifying the overall regimen. Following iterative medication adjustments, agitation improved without escalation of standing psychotropic medications. Morning alertness improved, with increased participation in therapy sessions, while motor function remained stable. This case highlights an individualized approach to balancing behavioral control, daytime alertness, and motor preservation in PD psychosis while illustrating how cumulative sedative burden and medication timing may influence functional outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.